What You Should Know:
– Sequel Med Tech, LLC, a company focused on developing cutting-edge insulin delivery technologies, has announced that its innovative twiist™ Automated Insulin Delivery (AID) System, powered by Tidepool, will be the…
Continue Reading
What You Should Know:
– Senseonics Holdings and Ascensia Diabetes Care today announced the integration of the Eversense® 365 Continuous Glucose Monitoring (CGM) System with the SweetSpot™ diabetes management platform in the U.S.
– The collaboration…
Continue Reading
This retrospective cohort study evaluates the impact of an AI-supported continuous glucose monitoring (CGM) mobile app (“January V2”) on glycemic control and weight management in 944 users, including healthy individuals and those with prediabetes…
Continue Reading
This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor.
The company added generative AI to its Stelo glucose monitor, which it began selling four months ago….
Continue Reading
What You Should Know:
– Dexcom, the global leader in continuous glucose monitoring (CGM), has achieved another groundbreaking milestone by launching the first generative AI (GenAI) platform in glucose biosensing technology, Stelo.
– The Stelo platform…
Continue Reading
Top News
CVC Capital Partners will likely acquire German health IT company CompuGroup Medical in a take-private deal valued at $1.2 billion. The acquisition is expected to close in the first half of 2025.
CGM…
What You Should Know:
– Tandem Diabetes Care, an insulin pump manufacturer, has announced expanded compatibility for its t:slim X2™ insulin pump in Canada.
– In-warranty users can now integrate their pumps with both the Dexcom…
Continue Reading
Introduction
Dexcom, a leader in continuous glucose monitoring (CGM) technology, has revolutionized diabetes management and ventured into broader health and wellness applications. With over 25 years of innovation, the company is forging partnerships and expanding…
Glucose-monitoring specialist Dexcom made several announcements this year, including receiving FDA clearance for its over-the-counter continuous glucose monitoring (CGM) solution Stelo, G7’s expanded capabilities to connect directly to the Apple Watch and, most recently,…
Continue Reading
Glucose-monitoring specialist Dexcom announced it has made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom’s continuous glucose monitor (CGM) and…
Continue Reading
